GL1X · GenesisL1 explorer

Research workbench

Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase

Analyse Structure-activity relationship guides enantiomeric preference among potent… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4ELE
Type
protein
Length
1,328 residues
Chains
8
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydrofolate reductase
EC
1.5.1.3
UniProt
Q81R22
Ligands
31I, CA, CL
Pockets
12 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 21% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, D, E, F, G, HDihydrofolate reductase (EC 1.5.1.3)protein16621% helix, 32% strandQ81R22

Ligands and binding sites

  • 31I · (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(propan-2-yl)phthalazin-2(1H)-yl]prop-2-en -1-one · ligand · 8 copies · chains A, B, C, D, E, F, G, H
  • CA · Calcium ion · metal · 8 copies · chains A, B, H, C, D, E, F, G
  • CL · Chloride ion · ion · 8 copies · chains A, B, C, D, E, F, G, H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 10 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16430.740.8159CL, 31I
24680.710.8152CL, 31I
33060.710.8442CL, 31I
43540.690.8244CL, 31I
53720.690.8144CL, 31I

Interfaces

15 interfaces between chains.

  • B–F · 455 Ų buried · 5 hydrogen bonds · protein-protein
  • F–G · 432 Ų buried · 5 hydrogen bonds · protein-protein
  • B–H · 429 Ų buried · 5 hydrogen bonds · protein-protein
  • A–C · 421 Ų buried · 3 hydrogen bonds · protein-protein
  • D–E · 416 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 4ELE · Structure-activity relationship guides enantiomeric preference among potent inhibitors of… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.